ReVENT® Medical, a privately held company founded in 2008, is focused on the development of an innovative surgical solution used by ENT surgeons to improve the quality of life for patients with Obstructive Sleep Apnea (OSA).

ReVENT Medical has developed the ReVENT Sleep Apnea System, which comprises minimally invasive, biocompatible implants; targeting tongue based OSA. The implants address the non-compliance issues inherent with CPAP and other daily therapies as well as the long and difficult procedural and recovery times associated with other surgical procedures for the treatment of OSA.

The device is CE marked for the European market and the company has several issued and pending US and OUS patents. The company has conducted a clinical trial in Europe and Canada. The device has not yet been reviewed by the US FDA and is not available for use or sale in the US.